Breast cancer patients who inherit germline mutations in these genes, in particular the BRCA1 carriers are commonly associated with triple negative breast cancer (TNBC), diagnosed at early onset (≤40 years), diagnosed with bilateral breast cancer, having family history of breast and/or ovarian cancers in the first- and second-degree relatives, and having an ovarian cancer [17–21]. The gene discussed is BRCA1; the disease is ovarian cancer.